Your MedTech works. The right funding route determines whether it scales.
UK MedTech funding spans grant bodies, strategic investors and trade buyers, each demanding a different pitch and evidence base. Most companies approach the wrong route first, losing time they cannot recover.
- steps
- 7
- steps
- to start
- 1 week
- to start
The short answer
Match the money to the milestone. Grants such as Innovate UK, NIHR i4i and SBRI Healthcare suit technical and evidence milestones; angels and EIS or SEIS investors suit early commercial proof; venture and strategic investors want repeatable revenue. Decide the next milestone, cost it, then approach only the funders who back that stage.
7 steps
Do it yourself: step by step
0 of 7 done
Write the one milestone that most increases your value: regulatory approval, a UK evaluation, first ten paying customers, or repeatable sales. Cost it with 20% contingency and add six months of runway
- Time
- 1 week
- Typical cost
- £0
- Who does it
- Founder and finance lead
Done when: One-page milestone plan with total funding required
This problem is Solvable.
Copy this table
Funding route matcher and investor tracker
Free to copy, adapt and use. No sign-up.
Part 1: Match the route to your milestone
| Your next milestone | Best-fit routes | What they want to see | Typical time to money |
|---|---|---|---|
| Prototype to validated device | Innovate UK competitions, NIHR i4i | Unmet need, technical plan, team, clinical partner | 6 to 12 months from application |
| UK evaluation or NHS adoption test | SBRI Healthcare, NIHR i4i, Health Innovation Network support | Defined NHS problem, evaluation plan | 6 to 12 months |
| First paying customers in independent sector | Angels, angel networks, SEIS and EIS funds | Early sales, pricing, credible team | 3 to 6 months |
| Repeatable sales and expansion | Healthcare venture funds, strategic investors | Revenue growth, retention, sales efficiency | 6 to 9 months |
| Exit or partnership | Trade buyers | Strategic fit, evidence, market position | 6 to 18 months |
(Timings are Solvable estimates. Always check current competitions and eligibility with each funder.)
Part 2: Milestone plan
- Milestone: [ ]
- Date: [ ]
- Cost to reach it: £[ ]
- Contingency (20%): £[ ]
- Six months runway after milestone: £[ ]
- Total to raise: £[ ]
Part 3: Funder tracker
| Funder | Type | Stage | Cheque size | Healthcare portfolio | Contact | Warm route | Status | Next step |
|---|---|---|---|---|---|---|---|---|
| [ ] | [Grant / angel / VC / strategic] | [ ] | £[ ] | [Yes / no, examples] | [ ] | [ ] | [ ] | [ ] |
Part 4: Data room contents
- Deck (investor version)
- Financial model with assumptions tab
- Cap table
- Regulatory status and roadmap
- Clinical and economic evidence summary
- Pipeline with named accounts and stage
- IP summary
- Team and advisers
- SEIS or EIS advance assurance letter
Avoid these
Common mistakes
- Sending a venture deck to grant funders and a grant application to investors.
- Raising for 'growth' without a costed milestone.
- Approaching generalist investors with no healthcare portfolio, who struggle with sales cycles and regulation.
- Letting fundraising drag over a year while sales stall.
- Raising from UK angels without SEIS or EIS advance assurance in place.

Free personal check
Done by Paul Robinson, not software
I'll read your pitch deck as a funder would and tell you which funding route fits your next milestone
What I need from you
- Your current pitch deck (PDF or PowerPoint)
- Your next milestone in one line
- How much you plan to raise
What you get
- Whether the deck matches the route you are pursuing
- The three gaps a funder will spot first
- Which grants or investor types to approach
Within 2 working days
No sign-in, no sales call. I read every request myself and reply on WhatsApp.
Free tools
Check where you stand
Benchmarks
SEIS and EIS advance assurance
Companies can ask HMRC to confirm in advance that a share issue is likely to qualify for SEIS or EIS
Source: HMRC, Venture capital schemes: apply for advance assurance
15 Health Innovation Networks
Regional NHS bodies in England that support evaluation and adoption, and promote SBRI Healthcare competitions
Source: The Health Innovation Network

Paul Robinson
14 years in UK private healthcare
I solve this one for healthcare companies
Want a hand? I'll look at your situation and tell you the three things I'd tackle first.
A few quick questions, about two minutes. I read every one myself and usually reply the same day.
No sales call unless you ask for one. Just a straight answer from me.
I reply personally, usually the same day.
Questions
Frequently asked questions
Should we go for grants or equity first?
Grants if the next milestone is technical or evidence based and you can wait 6 to 12 months. Equity if you need speed or commercial scale.
Do grants need match funding?
Often yes, depending on the competition and company size. Check each competition's rules.
What do healthcare investors ask about most?
Sales cycle length, who pays, regulatory status, evidence and how you will reach repeatable sales.
How long does a round take?
Plan for six to nine months from preparation to cash (Solvable estimate). Start before you have less than nine months of runway.
Should we talk to strategic investors early?
Yes, as partners and customers first. Their investment usually follows a commercial relationship.
Is this tax or investment advice?
No. This is general information. Take advice from a qualified accountant on SEIS and EIS, and from a lawyer on investment documents.
Last reviewed:
The Solvable community
You're not the only one with this problem.
One problem solved every week, on WhatsApp.
One message a week. No sales messages. Reply STOP any time.